YESCARTA is a treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, including DLBCL not otherwise specified, primary mediastinal large B-cell lymphoma, high grade B-cell lymphoma, and DLBCL arising from follicular lymphoma.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2BbIKEt
No comments:
Post a Comment